Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy.

Gkrouzman, Elena; Barbhaiya, Medha; Erkan, Doruk; Lockshin, Michael D

Gkrouzman, Elena; Barbhaiya, Medha; Erkan, Doruk; Lockshin, Michael D.

Affiliation

Gkrouzman E; Hospital for Special Surgery, Weill Cornell Medicine, New York, NY.
Barbhaiya M; Hospital for Special Surgery, Weill Cornell Medicine, New York, NY.
Erkan D; Hospital for Special Surgery, Weill Cornell Medicine, New York, NY.
Lockshin MD; Hospital for Special Surgery, Weill Cornell Medicine, New York, NY.

Arthritis Rheumatol ; 73(1): 173-174, 2021 01.

Article in En | MEDLINE | ID: mdl-32901454

Subject(s)

Antibodies, Antiphospholipid/immunology; Antiphospholipid Syndrome/diagnosis; COVID-19/immunology; Thrombophilia/immunology; Antibodies, Anticardiolipin/immunology; Antiphospholipid Syndrome/blood; Antiphospholipid Syndrome/immunology; COVID-19/blood; Humans; Immunoglobulin M/immunology; Lupus Coagulation Inhibitor/immunology; SARS-CoV-2; Thrombophilia/blood; Thrombosis/blood; Thrombosis/immunology; beta 2-Glycoprotein I/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiphospholipid Syndrome / Antibodies, Antiphospholipid / Thrombophilia / COVID-19 Type of study: Risk_factors_studies Limits: Humans Language: En Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google